← Leaderboards
Kathryn Jean Ruddy
Mayo Clinic Jacksonville
$3,623,191
Attributed
$8,095,967
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,095,967 · 3
By mechanism
R01$8,095,967 · 3
Top collaborators
- Joerg Herrmann6 shared
- Derek C Radisky4 shared
- Mark E Sherman4 shared
- Jeff Sloan Sloan2 shared
Most similar at Mayo Clinic Jacksonville
Same institution · by research overlap
- Mark E Sherman$5,733,205
- Nilufer Ertekin-Taner$28,054,444
- Joy Wolfram$1,077,811
Others in their field
Other Emerging Leaders on “Clinical Trials”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,363,765
- Beth Baseler · Leidos Biomedical Research, Inc.$207,964,226
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$177,411,785
Research focus
Clinical TrialsBloodClinicMalignant NeoplasmsMalignant Breast NeoplasmPreventivePrognosisIncidenceSymptomsCohortGeneticGenetic VariantBaseClinical CareCarvedilolAdultCaringCharacteristicsCardiotoxicityCardiovascular Risk FactorBiological MarkersCardioprotectionAdrenergic Beta-AntagonistsCardiomyopathies
Grant awards (12)
Targeted Prevention of Postpartum-Related Breast Cancer (PRBC)$650,300
R01 · FY2025 · CA
TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial$773,975
R01 · FY2024 · CA
Targeted Prevention of Postpartum-Related Breast Cancer (PRBC)$617,447
R01 · FY2024 · CA
TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial$798,417
R01 · FY2023 · CA
Targeted Prevention of Postpartum-Related Breast Cancer (PRBC)$653,945
R01 · FY2023 · CA
TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial$825,573
R01 · FY2022 · CA
Targeted Prevention of Postpartum-Related Breast Cancer (PRBC)$627,061
R01 · FY2022 · CA
TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial$1
R01 · FY2021 · CA
TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial$967,232
R01 · FY2020 · CA
Synergizing genome sequencing with advances in patient reprted outcomes (PRO)$586,464
R01 · FY2020 · NR · contact PI
TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial$951,993
R01 · FY2019 · CA
Synergizing genome sequencing with advances in patient reprted outcomes (PRO)$643,559
R01 · FY2019 · NR · contact PI